A magazine headline announcing an article about the groundbreaking human papilloma virus (HPV) vaccine proclaimed it “God’s gift to women”.
The vaccine, which is now given for free to 12 and 13-year-old schoolgirls to block four strains of the virus which causes cervical cancer, has won its creator, Professor Ian Frazer, a host of accolades.
The 2006 Australian and Queenslander of the Year can now add a Queen’s Birthday honour to the list.
Prof Frazer has been appointed a Companion in the Order of Australia (AC), for “eminent service to medical research, particularly through leadership roles in the discovery of the human papilloma virus vaccine and its role in preventing cervical cancer, to higher education and as a supporter of charitable organisations”.
Prof Frazer said the appointment recognised his work at a community, rather than a scientific, level.
“It suggests the research work that I and my colleagues have done is valued in the community as much as it is by other scientists,” he told AAP.
“It gives me the opportunity to go out there and tell everyone how important medical research is.”
Prof Frazer was awarded the Florey Medal for Medical Research in 2007, the 2008 Prime Minister’s Prize for Science and the Balzan Prize for Preventive Medicine.
The research director at Queensland’s Translational Research Institute is currently investigating a skin cancer vaccine, while also trying to develop a treatment for people already infected with HPV.
He is working with Brisbane-based biotechnology company Coridon on the new inoculation.
Born in Glasgow, Prof Frazer originally landed in Australia with his wife in 1981 to work at Melbourne’s Walter and Eliza Hall Institute for two years. He became an Australian citizen in 1998.
His three sons – aged 30, 27 and 25 – have all followed him into the medical field, with one practising as a vet in New Zealand while the other two are doctors.
At 59, Prof Frazer believes there’s still a lot more to achieve before retirement, although his wife regularly queries him about his intentions.
“I’ll retire when I feel I can’t contribute any more useful research work,” he said.
Related posts:
Views: 0